Streptococcus pneumoniae in community-acquired pneumonia -: How important is drug resistance?

被引:23
作者
Bauer, T
Ewig, S
Marcos, MA
Schultze-Werninghaus, G
Torres, A
机构
[1] Hosp Clin Barcelona, Serv Pneumol, Inst Clin Pneumol & Cirurg Torac, E-08036 Barcelona, Spain
[2] Univ Bonn, Med Klin & Poliklin 2, Dept Resp & Crit Care Med, D-5300 Bonn, Germany
[3] Hosp Clin Barcelona, Microbiol Serv, Inst Clin Infecc & Immunol, E-08036 Barcelona, Spain
关键词
D O I
10.1016/S0025-7125(05)70385-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Because the serum and pulmonary levels achieved with penicillin or related drugs are several times higher than the MICs of the strains, most pneumonias caused by S. pneumoniae currently defined as not susceptible to penicillin should respond well to treatment with a beta-lactam antibiotic using optimal dosing. All studies currently available comparing mortality between patients with pneumonia caused by nonsusceptible and susceptible pneumococci agree that resistance of up to MIC 2 mg/L is not independently associated with an increased mortality. Most, but not all, studies also could not prove an effect of microbial resistance on morbidity. Treatment failures, however, may occur at higher levels of resistance and, therefore, a change in the definition of susceptibility categories toward higher cut-offs for S. pneumoniae seems to be reasonable.
引用
收藏
页码:1367 / +
页数:14
相关论文
共 46 条
  • [1] A comparison of antimicrobial resistance rates in Gram-positive pathogens isolated in the UK from October 1996 to January 1997 and October 1997 to January 1998
    Andrews, J
    Ashby, J
    Jevons, G
    Marshall, T
    Lines, N
    Wise, R
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 45 (03) : 285 - 293
  • [2] Antipneumococcal activities of cefpirome and cefotaxime, alone and in combination with vancomycin and teicoplanin, determined by checkerboard and time-kill methods
    Bajaksouzian, S
    Visalli, MA
    Jacobs, MR
    Appelbaum, PC
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (09) : 1973 - 1976
  • [3] Bartlett J G, 1997, Semin Respir Infect, V12, P329
  • [4] Epidemiological features of and risk factors for infection by Streptococcus pneumoniae strains with diminished susceptibility to penicillin: Findings of a French survey
    Bedos, JP
    Chevret, S
    Chastang, C
    Geslin, P
    Regnier, B
    [J]. CLINICAL INFECTIOUS DISEASES, 1996, 22 (01) : 63 - 72
  • [5] Penicillin dosing for pneumococcal pneumonia
    Bryan, CS
    Talwani, R
    Stinson, S
    [J]. CHEST, 1997, 112 (06) : 1657 - 1664
  • [6] Current usefulness of procaine penicillin in the treatment of pneumococcal pneumonia
    Cabellos C.
    Ariza J.
    Barreiro B.
    Tubau F.
    Liñares J.
    Pallarés R.
    Manresa F.
    Gudiol F.
    [J]. European Journal of Clinical Microbiology and Infectious Diseases, 1998, 17 (4) : 265 - 268
  • [7] Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada
    Chen, DK
    McGeer, A
    de Azavedo, JC
    Low, DE
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (04) : 233 - 239
  • [8] Multivariate analysis of risk factors for infection due to penicillin-resistant and multidrug-resistant Streptococcus pneumoniae: A multicenter study
    ClavoSanchez, AJ
    GironGonzalez, JA
    LopezPrieto, D
    CanuetoQuintero, J
    SanchezPorto, A
    VergaraCampos, A
    MarinCasanova, P
    CordobaDona, JA
    [J]. CLINICAL INFECTIOUS DISEASES, 1997, 24 (06) : 1052 - 1059
  • [9] Synergy between amoxicillin and gentamicin in combination against a highly penicillin-resistant and -tolerant strain of Streptococcus pneumoniae in a mouse pneumonia model
    DarrasJoly, C
    Bedos, JP
    Sauve, C
    Moine, P
    Vallee, E
    Carbon, C
    AzoulayDupuis, E
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (09) : 2147 - 2151
  • [10] Pneumonia acquired in the community through drug-resistant Streptococcus pneumoniae
    Ewig, S
    Ruiz, M
    Torres, A
    Marco, F
    Martinez, JA
    Sanchez, M
    Mensa, J
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (06) : 1835 - 1842